130 related articles for article (PubMed ID: 17329104)
1. N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors.
Kiviranta PH; Leppänen J; Rinne VM; Suuronen T; Kyrylenko O; Kyrylenko S; Kuusisto E; Tervo AJ; Järvinen T; Salminen A; Poso A; Wallén EA
Bioorg Med Chem Lett; 2007 May; 17(9):2448-51. PubMed ID: 17329104
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the binding properties of SIRT2 inhibitors with a N-(3-phenylpropenoyl)-glycine tryptamide backbone.
Kiviranta PH; Salo HS; Leppänen J; Rinne VM; Kyrylenko S; Kuusisto E; Suuronen T; Salminen A; Poso A; Lahtela-Kakkonen M; Wallén EA
Bioorg Med Chem; 2008 Sep; 16(17):8054-62. PubMed ID: 18701307
[TBL] [Abstract][Full Text] [Related]
3. Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.
Huhtiniemi T; Suuronen T; Rinne VM; Wittekindt C; Lahtela-Kakkonen M; Jarho E; Wallén EA; Salminen A; Poso A; Leppänen J
J Med Chem; 2008 Aug; 51(15):4377-80. PubMed ID: 18642893
[TBL] [Abstract][Full Text] [Related]
4. N,N'-Bisbenzylidenebenzene-1,4-diamines and N,N'-Bisbenzylidenenaphthalene-1,4-diamines as Sirtuin Type 2 (SIRT2) Inhibitors.
Kiviranta PH; Leppänen J; Kyrylenko S; Salo HS; Lahtela-Kakkonen M; Tervo AJ; Wittekindt C; Suuronen T; Kuusisto E; Järvinen T; Salminen A; Poso A; Wallén EA
J Med Chem; 2006 Dec; 49(26):7907-11. PubMed ID: 17181175
[TBL] [Abstract][Full Text] [Related]
5. N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.
Kiviranta PH; Suuronen T; Wallén EA; Leppänen J; Tervonen J; Kyrylenko S; Salminen A; Poso A; Jarho EM
J Med Chem; 2009 Apr; 52(7):2153-6. PubMed ID: 19296597
[TBL] [Abstract][Full Text] [Related]
6. Identification of a small molecule SIRT2 inhibitor with selective tumor cytotoxicity.
Zhang Y; Au Q; Zhang M; Barber JR; Ng SC; Zhang B
Biochem Biophys Res Commun; 2009 Sep; 386(4):729-33. PubMed ID: 19559674
[TBL] [Abstract][Full Text] [Related]
7. An in silico approach to discovering novel inhibitors of human sirtuin type 2.
Tervo AJ; Kyrylenko S; Niskanen P; Salminen A; Leppänen J; Nyrönen TH; Järvinen T; Poso A
J Med Chem; 2004 Dec; 47(25):6292-8. PubMed ID: 15566299
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human sirtuins by in situ generation of an acetylated lysine-ADP-ribose conjugate.
Asaba T; Suzuki T; Ueda R; Tsumoto H; Nakagawa H; Miyata N
J Am Chem Soc; 2009 May; 131(20):6989-96. PubMed ID: 19413317
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.
Suzuki T; Khan MN; Sawada H; Imai E; Itoh Y; Yamatsuta K; Tokuda N; Takeuchi J; Seko T; Nakagawa H; Miyata N
J Med Chem; 2012 Jun; 55(12):5760-73. PubMed ID: 22642300
[TBL] [Abstract][Full Text] [Related]
10. Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2.
Galli U; Mesenzani O; Coppo C; Sorba G; Canonico PL; Tron GC; Genazzani AA
Eur J Med Chem; 2012 Sep; 55():58-66. PubMed ID: 22835719
[TBL] [Abstract][Full Text] [Related]
11. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1.
Westaway SM; Thompson M; Rami HK; Stemp G; Trouw LS; Mitchell DJ; Seal JT; Medhurst SJ; Lappin SC; Biggs J; Wright J; Arpino S; Jerman JC; Cryan JE; Holland V; Winborn KY; Coleman T; Stevens AJ; Davis JB; Gunthorpe MJ
Bioorg Med Chem Lett; 2008 Oct; 18(20):5609-13. PubMed ID: 18809327
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
[TBL] [Abstract][Full Text] [Related]
14. Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine.
Suzuki T; Asaba T; Imai E; Tsumoto H; Nakagawa H; Miyata N
Bioorg Med Chem Lett; 2009 Oct; 19(19):5670-2. PubMed ID: 19700324
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence assay of SIRT protein deacetylases using an acetylated peptide substrate and a secondary trypsin reaction.
Marcotte PA; Richardson PL; Guo J; Barrett LW; Xu N; Gunasekera A; Glaser KB
Anal Biochem; 2004 Sep; 332(1):90-9. PubMed ID: 15301953
[TBL] [Abstract][Full Text] [Related]
16. Discovering inhibitors of human sirtuin type 2: novel structural scaffolds.
Tervo AJ; Suuronen T; Kyrylenko S; Kuusisto E; Kiviranta PH; Salminen A; Leppänen J; Poso A
J Med Chem; 2006 Nov; 49(24):7239-41. PubMed ID: 17125277
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of N-nicotinoyl-tryptamine (tryptamide).
Eckstein M; Misztal S; Terczyńska A; Sienkiewicz B; Roszkowski A; Adamus M
Pol J Pharmacol Pharm; 1987; 39(6):725-7. PubMed ID: 2972997
[TBL] [Abstract][Full Text] [Related]
18. Simplification of the tetracyclic SIRT1-selective inhibitor MC2141: coumarin- and pyrimidine-based SIRT1/2 inhibitors with different selectivity profile.
Rotili D; Carafa V; Tarantino D; Botta G; Nebbioso A; Altucci L; Mai A
Bioorg Med Chem; 2011 Jun; 19(12):3659-68. PubMed ID: 21306905
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2.
Huhtiniemi T; Salo HS; Suuronen T; Poso A; Salminen A; Leppänen J; Jarho E; Lahtela-Kakkonen M
J Med Chem; 2011 Oct; 54(19):6456-68. PubMed ID: 21895016
[TBL] [Abstract][Full Text] [Related]
20. Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.
Disch JS; Evindar G; Chiu CH; Blum CA; Dai H; Jin L; Schuman E; Lind KE; Belyanskaya SL; Deng J; Coppo F; Aquilani L; Graybill TL; Cuozzo JW; Lavu S; Mao C; Vlasuk GP; Perni RB
J Med Chem; 2013 May; 56(9):3666-79. PubMed ID: 23570514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
